Eldepryl
TEMPO study
TEMPO extension trial
ELLDOPA trial Randomized placebo controlled trial of levodopa with clinical data showing neuroprotection with levodopa, but accelerated loss of dopamine terminals on beta-CIT imaging in the levodopa group.